Viewing Study NCT00134069


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2026-01-05 @ 8:19 AM
Study NCT ID: NCT00134069
Status: COMPLETED
Last Update Posted: 2014-04-16
First Post: 2005-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module